Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
morphinsulfat 8 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 25mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 50 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 5 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 4 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 200 mg/20 ml opløsnig |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 1 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 0,5 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 10 mg/10 ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 500 mg/20 ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfinsulfat 10 mg/5 ml sukkerfri oral opløsning 5 ml enhedsdosis, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing cyclizine and morphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine sulfate |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine phosphate hemihydrate (substance) |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Dihydrocodeine tartrate |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine phosphate |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine hydrochloride anhydrous (substance) |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine hydrochloride (substance) |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine phosphate anhydrous |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|